Diamond Drugs Private Limited, a active private limited company, was established on 15 December 2004 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239WB2004PTC100709. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.13 Cr.
It upholds a compliant status. Employing 84 professional, Its leadership includes Soumyajit Sarkar (Director), Mihir Sarkar (Director), Prabir Kumar Sarkar (Director). Past directors included Silpi Sarkar, Soumyajit Sarkar. It holds ₹1.10 Cr open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 37 Sri Gopal Mullick Lane, Kolkata, West Bengal, 700037.
U24239WB2004PTC100709
100709
15 December 2004
₹1.50 Cr
₹1.13 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Diamond Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Soumyajit Sarkar | Director | 06 Sep 2024 | Current |
| Mihir Sarkar | Director | 15 Dec 2004 | Current |
| Prabir Kumar Sarkar | Director | 15 Dec 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Aug 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Diamond Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.73% increase. The company also saw a substantial improvement in profitability, with a 99.37% increase in profit. The company's net worth Soared by an impressive increase of 31.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Diamond Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,000,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2015 | Yes Bank Limited | ₹1.10 Cr | Open |
| 03 Dec 2005 | State Bank Of India | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Diamond Drugs has a workforce of 84 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Diamond Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diamond Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Diamond Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Soumyajit Sarkar was appointed as a Director was appointed as a Director on 06 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.
The activity Diamond Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
A charge with Yes Bank Limited of Rs. 1.10 Cr registered on 28 Mar 2015 with Charge ID 10563720 was modified on 27 Jul 2018. was recorded as a recent event.
The activity A charge registered on 03 Dec 2005 via Charge ID 90370991 with State Bank Of India was fully satisfied on 07 Apr 2015. was completed.
The activity A charge with Yes Bank Limited amounted to Rs. 1.10 Cr with Charge ID 10563720 was registered on 28 Mar 2015. was completed.
The CIN of Diamond Drugs Private Limited is U24239WB2004PTC100709.
Diamond Drugs Private Limited is headquartered at 37 Sri Gopal Mullick Lane, Kolkata, West Bengal, 700037.
Diamond Drugs Private Limited was incorporated on 15 December 2004.
The current directors of Diamond Drugs Private Limited are
The primary industry of Diamond Drugs Private Limited is Manufacturing.
Diamond Drugs Private Limited is unlisted.
The authorized capital of Diamond Drugs Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.13 Cr.
The compliance status of Diamond Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX